These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28574407)

  • 1. Muscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophy.
    Jensen L; Petersson SJ; Illum NO; Laugaard-Jacobsen HC; Thelle T; Jørgensen LH; Schrøder HD
    J Musculoskelet Neuronal Interact; 2017 Jun; 17(2):8-18. PubMed ID: 28574407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deflazacort increases laminin expression and myogenic repair, and induces early persistent functional gain in mdx mouse muscular dystrophy.
    Anderson JE; Weber M; Vargas C
    Cell Transplant; 2000; 9(4):551-64. PubMed ID: 11038071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
    Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
    Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
    Balaban B; Matthews DJ; Clayton GH; Carry T
    Am J Phys Med Rehabil; 2005 Nov; 84(11):843-50. PubMed ID: 16244521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deflazacort treatment of Duchenne muscular dystrophy.
    Biggar WD; Gingras M; Fehlings DL; Harris VA; Steele CA
    J Pediatr; 2001 Jan; 138(1):45-50. PubMed ID: 11148511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
    Biggar WD; Politano L; Harris VA; Passamano L; Vajsar J; Alman B; Palladino A; Comi LI; Nigro G
    Neuromuscul Disord; 2004 Sep; 14(8-9):476-82. PubMed ID: 15336688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapy.
    Mayo AL; Craven BC; McAdam LC; Biggar WD
    Neuromuscul Disord; 2012 Dec; 22(12):1040-5. PubMed ID: 22824639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy.
    Silversides CK; Webb GD; Harris VA; Biggar DW
    Am J Cardiol; 2003 Mar; 91(6):769-72. PubMed ID: 12633823
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
    Houde S; Filiatrault M; Fournier A; Dubé J; D'Arcy S; Bérubé D; Brousseau Y; Lapierre G; Vanasse M
    Pediatr Neurol; 2008 Mar; 38(3):200-6. PubMed ID: 18279756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
    Wong BL; Christopher C
    J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.
    McDonald CM; Sajeev G; Yao Z; McDonnell E; Elfring G; Souza M; Peltz SW; Darras BT; Shieh PB; Cox DA; Landry J; Signorovitch J;
    Muscle Nerve; 2020 Jan; 61(1):26-35. PubMed ID: 31599456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of the T2 relaxation time of the gluteus muscles in children with Duchenne muscular dystrophy: a comparative study before and after steroid treatment.
    Kim HK; Laor T; Horn PS; Wong B
    Korean J Radiol; 2010; 11(3):304-11. PubMed ID: 20461184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway.
    St-Pierre SJ; Chakkalakal JV; Kolodziejczyk SM; Knudson JC; Jasmin BJ; Megeney LA
    FASEB J; 2004 Dec; 18(15):1937-9. PubMed ID: 15456738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort.
    Archer JD; Vargas CC; Anderson JE
    FASEB J; 2006 Apr; 20(6):738-40. PubMed ID: 16464957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy.
    de Carvalho SC; Matsumura CY; Santo Neto H; Marques MJ
    Cytokine; 2018 Feb; 102():55-61. PubMed ID: 29276972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.
    Joseph S; Wang C; Bushby K; Guglieri M; Horrocks I; Straub V; Ahmed SF; Wong SC;
    JAMA Neurol; 2019 Jun; 76(6):701-709. PubMed ID: 30855644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy.
    Pereira JA; Marques MJ; Santo Neto H
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):788-94. PubMed ID: 25959722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological effects of givinostat in boys with Duchenne muscular dystrophy.
    Bettica P; Petrini S; D'Oria V; D'Amico A; Catteruccia M; Pane M; Sivo S; Magri F; Brajkovic S; Messina S; Vita GL; Gatti B; Moggio M; Puri PL; Rocchetti M; De Nicolao G; Vita G; Comi GP; Bertini E; Mercuri E
    Neuromuscul Disord; 2016 Oct; 26(10):643-649. PubMed ID: 27566866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.